BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 25327679)

  • 1. [Possibilities of treatment of external pancreatic fistula].
    Cherdantsev DV; Pervova OV; Diatlov VIu; Kurbanov DSh
    Khirurgiia (Mosk); 2014; (8):62-6. PubMed ID: 25327679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experience of using of octreotide-depot in prevention of the development and treatment of external pancreatic fistulas of different genesis].
    Kabanov MIu; Solov'ev IA; Iakovleva DM; Sementsov KV; Kradenov AV
    Vestn Khir Im I I Grek; 2013; 172(3):94-6. PubMed ID: 24340982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of somatostatin or octreotide efficacy in the treatment of external pancreatic fistulas].
    Brunaud L; Sebbag H; Marchal F; Verdier A; Bresler L; Tortuyaux JM; Boissel P
    Ann Chir; 2001 Feb; 126(1):34-41. PubMed ID: 11255969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of external biliary, pancreatic and intestinal fistulas with a somatostatin analog.
    Kocak S; Bumin C; Karayalcin K; Alacayir I; Aribal D
    Dig Dis; 1994; 12(1):62-8. PubMed ID: 8200125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of somatostatin and octreotide in the treatment of pancreatic pseudocyst, fistula and ascites.
    Grauer L; Barkin JS
    Digestion; 1994; 55 Suppl 1():24-8. PubMed ID: 7907566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management of postoperative pancreatic fistula resistant to octreotide therapy].
    Dobosz M; Dymecki D; Babicki A; Hać S; Gruca Z; Wajda Z
    Wiad Lek; 2001; 54(7-8):380-5. PubMed ID: 11641892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of somatostatin or an analog to promote closure of end pancreatic fistulae.
    Miller BM; Traverso LW; Freeny PC; Abumrad NN
    Int J Pancreatol; 1989 Feb; 4(1):65-72. PubMed ID: 2466917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short report: octreotide in the treatment of external pancreatic fistulas.
    Tulassay Z; Flautner L; Vadász A; Fehérvári I
    Aliment Pharmacol Ther; 1993 Jun; 7(3):323-5. PubMed ID: 8364137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is octreotide a new hope for enterocutaneous and external pancreatic fistulas closure?
    Martineau P; Shwed JA; Denis R
    Am J Surg; 1996 Oct; 172(4):386-95. PubMed ID: 8873537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The administration of sandostatin in the combined treatment of acute pancreatitis and its complications].
    Saenko VF; Lupal'tsov VI; Babenkov GF; Kopchak VM; Volzhanskiĭ AP
    Klin Khir; 1999; (10):5-7. PubMed ID: 10584505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin versus octreotide in the treatment of patients with gastrointestinal and pancreatic fistulas.
    Leandros E; Antonakis PT; Albanopoulos K; Dervenis C; Konstadoulakis MM
    Can J Gastroenterol; 2004 May; 18(5):303-6. PubMed ID: 15152279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term administration of SMS 201-995 in the management of an external pancreatic fistula.
    Kwan D; Aufses AH
    Am J Gastroenterol; 1989 Mar; 84(3):326-8. PubMed ID: 2919593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of pancreatic cutaneous fistulas with a somatostatin analog.
    Prinz RA; Pickleman J; Hoffman JP
    Am J Surg; 1988 Jan; 155(1):36-42. PubMed ID: 2893556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are somatostatin analogues (octreotide and lanreotide) effective in promoting healing of enterocutaneous fistulas?
    Gray M; Jacobson T
    J Wound Ostomy Continence Nurs; 2002 Sep; 29(5):228-33. PubMed ID: 12510468
    [No Abstract]   [Full Text] [Related]  

  • 15. Randomized double-blind placebo-controlled trial of early octreotide in patients with postoperative enterocutaneous fistula.
    Sancho JJ; di Costanzo J; Nubiola P; Larrad A; Beguiristain A; Roqueta F; Franch G; Oliva A; Gubern JM; Sitges-Serra A
    Br J Surg; 1995 May; 82(5):638-41. PubMed ID: 7613936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of a high-output fistula with a somatostatin analogue following pancreas transplantation.
    Cooper MM; Wright FH; Smith JL; Corry RJ
    Transplant Proc; 1989 Aug; 21(4):3738-41. PubMed ID: 2474877
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of somatostatin analogue for intestinal and pancreatic fistulas].
    Paran H; Neufeld D; Epstein T; Bendahan J; Freund U
    Harefuah; 1991 Feb; 120(4):185-6. PubMed ID: 2066018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pancreatico-pleural fistula in chronic pancreatitis with necrosis of the pancreatic tail].
    Neumann S; Caca K; Mössner J
    Dtsch Med Wochenschr; 2004 Aug; 129(34-35):1802-5. PubMed ID: 15314743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, placebo-controlled, double-blind study of the efficacy of lanreotide 30 mg PR in the treatment of pancreatic and enterocutaneous fistulae.
    Gayral F; Campion JP; Regimbeau JM; Blumberg J; Maisonobe P; Topart P; Wind P;
    Ann Surg; 2009 Dec; 250(6):872-7. PubMed ID: 19953707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of octreotide in the treatment of external pancreatic pure fistulas: a single-institution prospective experience.
    Bassi C; Falconi M; Salvia R; Caldiron E; Butturini G; Pederzoli P
    Langenbecks Arch Surg; 2000 Jan; 385(1):10-3. PubMed ID: 10664113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.